Showing results (61-70 of 117) with videos related to
Sort By:
Pageof 12
Nature|May 31, 1990
Presentation of viral antigen controlled by a gene in the major histocompatibility complexV Cerundolo, J Alexander, K Anderson, et al.European Journal of Immunology|January 1, 1997
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cellsV Cerundolo, A Benham, V Braud, et al.British Journal of Cancer|March 29, 2000
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexesG S Ogg, P R Dunbar, V Cerundolo, et al.International Immunology|June 1, 1995
Isolation of a human allo-peptide presented by HLA-B51 moleculesH Tomiyama, Y Takamiya, A B Hill, et al.The Journal of Experimental Medicine|October 9, 1998
Essential and partially overlapping role of CD3gamma and CD3delta for development of alphabeta and gammadelta T lymphocytesB Wang, N Wang, M Salio, et al.Molecular Medicine (Cambridge, Mass.)|January 1, 1997
CD3-epsilon overexpressed in prothymocytes acts as an oncogeneB Wang, J She, M Salio, et al.FEBS Letters|July 14, 1999
Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathwayK L Noakes, H T Teisserenc, J M Lord, et al.Immunology Letters|June 1, 1997
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathwayH Teisserenc, W Schmitt, N Blake, et al.Human Immunology|October 31, 1998
Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cellsN T Young, N A Rust, M J Dallman, et al.The Journal of Experimental Medicine|January 31, 1998
Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacAM Molinari, M Salio, C Galli, et al.Pageof 12